| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |